Next |
home / stock / abbv / abbv message board
News, Short Squeeze, Breakout and More Instantly...
AbbVie Receives Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis PR Newswire The positive opinion is based on results from two pivotal Phase 3 trials, INSPIRE and COMMAND, that evaluated ...
2024-05-30 05:45:00 ET Sometimes, misperceptions can work in investors' favor. When others think the outlook for a stock isn't so great, you can win big if that view is overly pessimistic. Several stocks that pay fantastic dividends are in that category. Here are three dividend stocks t...
NEW YORK, NY / ACCESSWIRE / May 29, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Cerevel Therapeutics Holdings, Inc. ("Cerevel") (NASDAQ:CERE) and AbbVie, Inc. ("AbbVie") (NYSE:ABBV). Investors who purchased Cerevel and continue to holdto the present are enco...